Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome

Sjögren’s syndrome is a chronic systemic autoimmune disease affecting from 0.2 to 3% of the general population. The current treatment for Sjögren’s syndrome is aimed at controlling symptoms such as dry eyes and xerostomia. Systemic therapy with glucocorticoids or immunosuppressants is also used. Bar...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrós, Núria, Mallandrich, Mireia, Beirampour, Negar, Mohammadi, Roya, Domènech, Òscar, Rodríguez-Lagunas, Maria José, Clares, Beatriz, Colom, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505846/
https://www.ncbi.nlm.nih.gov/pubmed/36145642
http://dx.doi.org/10.3390/pharmaceutics14091895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505846/
https://www.ncbi.nlm.nih.gov/pubmed/36145642
http://dx.doi.org/10.3390/pharmaceutics14091895

Ejemplares similares